227 related articles for article (PubMed ID: 37483544)
21. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
[TBL] [Abstract][Full Text] [Related]
22. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
[TBL] [Abstract][Full Text] [Related]
23. Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.
Damask C; Chen M; Holweg CTJ; Yoo B; Millette LA; Franzese C
Am J Rhinol Allergy; 2022 Jan; 36(1):135-141. PubMed ID: 34382434
[TBL] [Abstract][Full Text] [Related]
24. Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds.
Chuang CC; Guillemin I; Bachert C; Lee SE; Hellings PW; Fokkens WJ; Duverger N; Fan C; Daizadeh N; Amin N; Mannent LP; Khan AH; Kamat S
Laryngoscope; 2022 Feb; 132(2):259-264. PubMed ID: 34817082
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Their Clinical Comparison in Indian Population.
Guthikonda MR; Gude A; Nutakki A
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):994-1000. PubMed ID: 36452721
[TBL] [Abstract][Full Text] [Related]
26. Subjective symptoms as predictors for eosinophilic chronic rhinosinusitis with nasal polyps in the Chinese population.
Zhang C; Wang H; Zhang Q; Chen J; Yu H; Li W; Xu H; Hu L; Wang D; Sun X
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3721-3729. PubMed ID: 36917251
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
Price CPE; Guo A; Stevens WW; Cousens L; Vu TT; Suh LA; Erickson KA; Conley D; Grammer LC; Kern RC; Tan BK; Kato A; Schleimer RP; Smith SS; Welch KC; Peters AT
Clin Exp Allergy; 2022 Jul; 52(7):859-867. PubMed ID: 35524339
[TBL] [Abstract][Full Text] [Related]
28. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
[TBL] [Abstract][Full Text] [Related]
29. [A comparative study of artificial intelligence nasal polyp classification based on whole-slide imaging and JESREC diagnostic criteria].
Wu QW; Kong WF; Yuan LX; Ren Y; Zhang YN; Deng HY; Luo X; Chen JN; Huang XK; Yang QT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Feb; 57(2):136-141. PubMed ID: 35196756
[No Abstract] [Full Text] [Related]
30. Efficacy and Safety of Anti-Interleukin-5 Therapies in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wang Q; Sun Q; Chen Q; Li H; Liu D; Wu Q
Int Arch Allergy Immunol; 2022; 183(7):732-743. PubMed ID: 35108711
[TBL] [Abstract][Full Text] [Related]
31. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.
Desrosiers M; Diamant Z; Castelnuovo P; Hellings PW; Han JK; Peters AT; Silver J; Smith SG; Fuller A; Sousa AR; Chan RH; Gevaert P;
Int Forum Allergy Rhinol; 2024 Jan; 14(1):18-31. PubMed ID: 37345861
[TBL] [Abstract][Full Text] [Related]
32. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
[TBL] [Abstract][Full Text] [Related]
33. Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
Busse WW; Pavord ID; Siddiqui S; Khan AH; Praestgaard A; Nash S; Jacob-Nara JA; Rowe PJ; Deniz Y
J Asthma Allergy; 2023; 16():411-419. PubMed ID: 37096015
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.
Gevaert P; Saenz R; Corren J; Han JK; Mullol J; Lee SE; Ow RA; Zhao R; Howard M; Wong K; Islam L; Ligueros-Saylan M; Omachi TA; Bachert C
J Allergy Clin Immunol; 2022 Mar; 149(3):957-965.e3. PubMed ID: 34530020
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of buffered hypertonic seawater in different phenotypes of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery: a randomized double-blind study.
Wang J; Shen L; Huang ZQ; Luo Q; Li MY; Tu JH; Han M; Ye J
Am J Otolaryngol; 2020; 41(5):102554. PubMed ID: 32521299
[TBL] [Abstract][Full Text] [Related]
36. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
37. [Expression and predictive value of type Ⅱ inflammatory cytokines in nasal secretion in eosinophilic chronic rhinosinusitis with nasal polyps].
Zhang Z; Ma F; Liu J; Xie L; Cao W; Zhang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 36(12):934-939. PubMed ID: 36543402
[No Abstract] [Full Text] [Related]
38. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis.
Small CB; Hernandez J; Reyes A; Schenkel E; Damiano A; Stryszak P; Staudinger H; Danzig M
J Allergy Clin Immunol; 2005 Dec; 116(6):1275-81. PubMed ID: 16337459
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
Bachert C; Han JK; Desrosiers MY; Gevaert P; Heffler E; Hopkins C; Tversky JR; Barker P; Cohen D; Emson C; Martin UJ; Shih VH; Necander S; Kreindler JL; Jison M; Werkström V
J Allergy Clin Immunol; 2022 Apr; 149(4):1309-1317.e12. PubMed ID: 34599979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]